[Colon cancer and COX-2].
Ota
Shinichi
S
3rd Department of Internal Medicine, Saitama Medical School.
Bamba
Hiromi
H
Imai
Yukinori
Y
Arai
Shin
S
Fujiwara
Kenji
K
D011125:Adenomatous Polyposis Coli / Q000517:prevention & control; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D003110:Colonic Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000517:prevention & control*; D051546:Cyclooxygenase 2; D016228:Endothelial Growth Factors / Q000096:biosynthesis; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis* / Q000502:physiology; D008222:Lymphokines / Q000096:biosynthesis; D008565:Membrane Proteins; D051379:Mice; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis* / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016228:Endothelial Growth Factors; D007527:Isoenzymes; D008222:Lymphokines; D008565:Membrane Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin